218 related articles for article (PubMed ID: 9926939)
1. Cyclin D1 associates with the TBP-associated factor TAF(II)250 to regulate Sp1-mediated transcription.
Adnane J; Shao Z; Robbins PD
Oncogene; 1999 Jan; 18(1):239-47. PubMed ID: 9926939
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of D-type cyclins, E2F-1, SV40 large T antigen and HPV16 E7 rescue cell cycle arrest of tsBN462 cells caused by the CCG1/TAF(II)250 mutation.
Sekiguchi T; Nishimoto T; Hunter T
Oncogene; 1999 Mar; 18(10):1797-806. PubMed ID: 10086334
[TBL] [Abstract][Full Text] [Related]
3. Cyclin D1 suppresses retinoblastoma protein-mediated inhibition of TAFII250 kinase activity.
Siegert JL; Rushton JJ; Sellers WR; Kaelin WG; Robbins PD
Oncogene; 2000 Nov; 19(50):5703-11. PubMed ID: 11126356
[TBL] [Abstract][Full Text] [Related]
4. Differential regulation of transcription of p21 and cyclin D1 conferred by TAF(II)250.
Rushton JJ; Steinman RA; Robbins PD
Cell Growth Differ; 1997 Oct; 8(10):1099-104. PubMed ID: 9342188
[TBL] [Abstract][Full Text] [Related]
5. Regulation of the cyclin D1 and cyclin A1 promoters by B-Myb is mediated by Sp1 binding sites.
Bartusel T; Schubert S; Klempnauer KH
Gene; 2005 May; 351():171-80. PubMed ID: 15922873
[TBL] [Abstract][Full Text] [Related]
6. TAF(II)170 interacts with the concave surface of TATA-binding protein to inhibit its DNA binding activity.
Pereira LA; van der Knaap JA; van den Boom V; van den Heuvel FA; Timmers HT
Mol Cell Biol; 2001 Nov; 21(21):7523-34. PubMed ID: 11585931
[TBL] [Abstract][Full Text] [Related]
7. Direct interaction of p21 cyclin-dependent kinase inhibitor with the retinoblastoma tumor suppressor protein.
Nakanishi M; Kaneko Y; Matsushime H; Ikeda K
Biochem Biophys Res Commun; 1999 Sep; 263(1):35-40. PubMed ID: 10486249
[TBL] [Abstract][Full Text] [Related]
8. The ts13 mutation in the TAF(II)250 subunit (CCG1) of TFIID directly affects transcription of D-type cyclin genes in cells arrested in G1 at the nonpermissive temperature.
Suzuki-Yagawa Y; Guermah M; Roeder RG
Mol Cell Biol; 1997 Jun; 17(6):3284-94. PubMed ID: 9154827
[TBL] [Abstract][Full Text] [Related]
9. DNA binding site selection by RNA polymerase II TAFs: a TAF(II)250-TAF(II)150 complex recognizes the initiator.
Chalkley GE; Verrijzer CP
EMBO J; 1999 Sep; 18(17):4835-45. PubMed ID: 10469661
[TBL] [Abstract][Full Text] [Related]
10. Modular organization of the E2F1 activation domain and its interaction with general transcription factors TBP and TFIIH.
Pearson A; Greenblatt J
Oncogene; 1997 Nov; 15(22):2643-58. PubMed ID: 9400991
[TBL] [Abstract][Full Text] [Related]
11. The retinoblastoma-susceptibility gene product binds directly to the human TATA-binding protein-associated factor TAFII250.
Shao Z; Ruppert S; Robbins PD
Proc Natl Acad Sci U S A; 1995 Apr; 92(8):3115-9. PubMed ID: 7724524
[TBL] [Abstract][Full Text] [Related]
12. Activation of the E2F transcription factor by cyclin D1 is blocked by p16INK4, the product of the putative tumor suppressor gene MTS1.
Schulze A; Zerfass K; Spitkovsky D; Henglein B; Jansen-Dürr P
Oncogene; 1994 Dec; 9(12):3475-82. PubMed ID: 7970707
[TBL] [Abstract][Full Text] [Related]
13. Cyclin D-cdk4 activity modulates the subnuclear localization and interaction of MEF2 with SRC-family coactivators during skeletal muscle differentiation.
Lazaro JB; Bailey PJ; Lassar AB
Genes Dev; 2002 Jul; 16(14):1792-805. PubMed ID: 12130539
[TBL] [Abstract][Full Text] [Related]
14. Function of TAF(II)-containing complex without TBP in transcription by RNA polymerase II.
Wieczorek E; Brand M; Jacq X; Tora L
Nature; 1998 May; 393(6681):187-91. PubMed ID: 9603525
[TBL] [Abstract][Full Text] [Related]
15. Sp1 inhibits proliferation and induces apoptosis in vascular smooth muscle cells by repressing p21WAF1/Cip1 transcription and cyclin D1-Cdk4-p21WAF1/Cip1 complex formation.
Kavurma MM; Khachigian LM
J Biol Chem; 2003 Aug; 278(35):32537-43. PubMed ID: 12796485
[TBL] [Abstract][Full Text] [Related]
16. TAFII55 binding to TAFII250 inhibits its acetyltransferase activity.
Gegonne A; Weissman JD; Singer DS
Proc Natl Acad Sci U S A; 2001 Oct; 98(22):12432-7. PubMed ID: 11592977
[TBL] [Abstract][Full Text] [Related]
17. Transcription factors of the Sp1 family: interaction with E2F and regulation of the murine thymidine kinase promoter.
Rotheneder H; Geymayer S; Haidweger E
J Mol Biol; 1999 Nov; 293(5):1005-15. PubMed ID: 10547281
[TBL] [Abstract][Full Text] [Related]
18. An inhibitor domain in Sp3 regulates its glutamine-rich activation domains.
Dennig J; Beato M; Suske G
EMBO J; 1996 Oct; 15(20):5659-67. PubMed ID: 8896459
[TBL] [Abstract][Full Text] [Related]
19. CCG1/TAF(II)250 regulates epidermal growth factor receptor gene transcription in cell cycle mutant ts13.
Vargas GA; Isas JM; Fantino E; Gargus JJ; Haigler HT
J Cell Physiol; 1998 Sep; 176(3):642-7. PubMed ID: 9699517
[TBL] [Abstract][Full Text] [Related]
20. Assembly of partial TFIID complexes in mammalian cells reveals distinct activities associated with individual TATA box-binding protein-associated factors.
Furukawa T; Tanese N
J Biol Chem; 2000 Sep; 275(38):29847-56. PubMed ID: 10896937
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
